Suppr超能文献

[托派芬和芬托拉明对肾上腺素、去甲肾上腺素、血清素及其他生物活性物质致痉挛作用的影响]

[Effect of tropaphene and fentolamin on the spasmogenic effects of adrenaline, noradrenaline, serotonin and other biologically active substances].

作者信息

Shvarts G Ia

出版信息

Farmakol Toksikol. 1978 Mar-Apr;41(2):142-6.

PMID:26588
Abstract

Tests conducted in vitro and in vivo demonstrated that tropaphen, tropine ether of alpha-phenyl-beta-(p-acetoxyphenyl)-propionic acid, an original alpha-adrenoblocking agent, display a marked antiserotonin activity exceeding that of phentolamine. Moreover, tropaphen is more active that phenolamine by its inhibiting influence on the spasmogenous effects of histamine, angiotensin, bradykinine and prostaglandin E2. In doses of 0.1 and 0.25 mg/kg both drugs had no effect on changes of the arterial pressure in anesthetized rats, caused by the above mentioned biologically active substances.

摘要

体外和体内实验表明,托拉芬,即α-苯基-β-(对乙酰氧基苯基)-丙酸的托品醚,一种新型α-肾上腺素能阻滞剂,具有显著的抗血清素活性,超过酚妥拉明。此外,托拉芬对组胺、血管紧张素、缓激肽和前列腺素E2的致痉挛作用的抑制作用比酚妥拉明更强。在0.1和0.25mg/kg剂量下,两种药物对上述生物活性物质引起的麻醉大鼠动脉血压变化均无影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验